Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability

The uptake of contralateral prophylactic mastectomy (CPM) has increased steadily over the last twenty years in women of all age groups and breast cancer stages. Since contralateral breast cancer is relatively rare and the breast cancer guidelines only recommend CPM in a small subset of patients with...

Full description

Bibliographic Details
Main Authors: Josien C.C. Scheepens, Laura van ’t Veer, Laura Esserman, Jeff Belkora, Rita A. Mukhtar
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:Breast
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977621000175
id doaj-904cc8df008b46a7b59306342ed79a97
record_format Article
spelling doaj-904cc8df008b46a7b59306342ed79a972021-03-17T04:13:24ZengElsevierBreast1532-30802021-04-01566169Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptabilityJosien C.C. Scheepens0Laura van ’t Veer1Laura Esserman2Jeff Belkora3Rita A. Mukhtar4University of California, San Francisco, Department of Laboratory Medicine, 2340 Sutter St., Box 0808, San Francisco, CA, 94115, USAUniversity of California, San Francisco, Department of Laboratory Medicine, 2340 Sutter St., Box 0808, San Francisco, CA, 94115, USAUniversity of California, San Francisco, Department of Surgery, 1825 4th Street, 3rd Floor, Box 1710, San Francisco, CA, 94143-1710, USAUniversity of California, San Francisco, Institute for Health Policy Studies and Department of Surgery, 3333 California Street, Suite 265, San Francisco, CA, 94118, USAUniversity of California, San Francisco, Department of Surgery, 1825 4th Street, 3rd Floor, Box 1710, San Francisco, CA, 94143-1710, USA; Corresponding author.The uptake of contralateral prophylactic mastectomy (CPM) has increased steadily over the last twenty years in women of all age groups and breast cancer stages. Since contralateral breast cancer is relatively rare and the breast cancer guidelines only recommend CPM in a small subset of patients with breast cancer, the drivers of this trend are unknown. This review aims to evaluate the evidence for and acceptability of CPM, data on patient rationales for choosing CPM, and some of the factors that might impact patient preferences. Based on the evidence, future recommendations will be provided. First, data on contralateral breast cancer risk and CPM rates and trends are addressed. After that, the evidence is structured around four main patient rationales for CPM formulated as questions that patients might ask their surgeon: Will CPM reduce mortality risk? Will CPM reduce the risk of contralateral breast cancer? Can I avoid future screening with CPM? Will I have better breast symmetry after CPM? Also, three different guidelines regarding CPM will be reviewed. Studies indicate a large gap between patient preferences for radical risk reduction with CPM and the current approaches recommended by important guidelines. We suggest a strategy including shared decision-making to enhance surgeons’ communication with patients about contralateral breast cancer and treatment options, to empower patients in order to optimize the use of CPM incorporating accurate risk assessment and individual patient preferences.http://www.sciencedirect.com/science/article/pii/S0960977621000175Contralateral prophylactic mastectomy (CPM)Breast cancerContralateral breast cancerBreast cancer risk reductionPatient preferenceShared decision-making
collection DOAJ
language English
format Article
sources DOAJ
author Josien C.C. Scheepens
Laura van ’t Veer
Laura Esserman
Jeff Belkora
Rita A. Mukhtar
spellingShingle Josien C.C. Scheepens
Laura van ’t Veer
Laura Esserman
Jeff Belkora
Rita A. Mukhtar
Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability
Breast
Contralateral prophylactic mastectomy (CPM)
Breast cancer
Contralateral breast cancer
Breast cancer risk reduction
Patient preference
Shared decision-making
author_facet Josien C.C. Scheepens
Laura van ’t Veer
Laura Esserman
Jeff Belkora
Rita A. Mukhtar
author_sort Josien C.C. Scheepens
title Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability
title_short Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability
title_full Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability
title_fullStr Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability
title_full_unstemmed Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability
title_sort contralateral prophylactic mastectomy: a narrative review of the evidence and acceptability
publisher Elsevier
series Breast
issn 1532-3080
publishDate 2021-04-01
description The uptake of contralateral prophylactic mastectomy (CPM) has increased steadily over the last twenty years in women of all age groups and breast cancer stages. Since contralateral breast cancer is relatively rare and the breast cancer guidelines only recommend CPM in a small subset of patients with breast cancer, the drivers of this trend are unknown. This review aims to evaluate the evidence for and acceptability of CPM, data on patient rationales for choosing CPM, and some of the factors that might impact patient preferences. Based on the evidence, future recommendations will be provided. First, data on contralateral breast cancer risk and CPM rates and trends are addressed. After that, the evidence is structured around four main patient rationales for CPM formulated as questions that patients might ask their surgeon: Will CPM reduce mortality risk? Will CPM reduce the risk of contralateral breast cancer? Can I avoid future screening with CPM? Will I have better breast symmetry after CPM? Also, three different guidelines regarding CPM will be reviewed. Studies indicate a large gap between patient preferences for radical risk reduction with CPM and the current approaches recommended by important guidelines. We suggest a strategy including shared decision-making to enhance surgeons’ communication with patients about contralateral breast cancer and treatment options, to empower patients in order to optimize the use of CPM incorporating accurate risk assessment and individual patient preferences.
topic Contralateral prophylactic mastectomy (CPM)
Breast cancer
Contralateral breast cancer
Breast cancer risk reduction
Patient preference
Shared decision-making
url http://www.sciencedirect.com/science/article/pii/S0960977621000175
work_keys_str_mv AT josienccscheepens contralateralprophylacticmastectomyanarrativereviewoftheevidenceandacceptability
AT lauravantveer contralateralprophylacticmastectomyanarrativereviewoftheevidenceandacceptability
AT lauraesserman contralateralprophylacticmastectomyanarrativereviewoftheevidenceandacceptability
AT jeffbelkora contralateralprophylacticmastectomyanarrativereviewoftheevidenceandacceptability
AT ritaamukhtar contralateralprophylacticmastectomyanarrativereviewoftheevidenceandacceptability
_version_ 1724218908046524416